877 related articles for article (PubMed ID: 11606380)
1. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
2. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
4. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
Kisková T; Jendželovský R; Rentsen E; Maier-Salamon A; Kokošová N; Papčová Z; Mikeš J; Orendáš P; Bojková B; Kubatka P; Svoboda M; Kajo K; Fedoročko P; Jäger W; Ekmekcioglu C; Kassayová M; Thalhammer T
Eur J Cancer Prev; 2014 Nov; 23(6):506-13. PubMed ID: 25254309
[TBL] [Abstract][Full Text] [Related]
6. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.
Waffo-Téguo P; Hawthorne ME; Cuendet M; Mérillon JM; Kinghorn AD; Pezzuto JM; Mehta RG
Nutr Cancer; 2001; 40(2):173-9. PubMed ID: 11962253
[TBL] [Abstract][Full Text] [Related]
7. A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Kisková T; Ekmekcioglu C; Garajová M; Orendáš P; Bojková B; Bobrov N; Jäger W; Kassayová M; Thalhammer T
Eur J Cancer Prev; 2012 Mar; 21(2):163-70. PubMed ID: 22044852
[TBL] [Abstract][Full Text] [Related]
8. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
10. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.
Cabanes A; Wang M; Olivo S; DeAssis S; Gustafsson JA; Khan G; Hilakivi-Clarke L
Carcinogenesis; 2004 May; 25(5):741-8. PubMed ID: 14729590
[TBL] [Abstract][Full Text] [Related]
11. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic activity in white and red wine extracts.
Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
[TBL] [Abstract][Full Text] [Related]
13. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
Liao DZ; Pantazis CG; Hou X; Li SA
Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
17. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
